Dietary resistant starch increases hypothalamic POMC expression in rats.
Resistant starch (RS) is fermentable dietary fiber. Inclusion of RS in the diet causes decreased body fat accumulation and altered gut hormone profile. This study investigates the effect of feeding RS on the neuropeptide messenger RNA (mRNA) expressions in the arcuate nucleus (ARC) of the hypothalamus and whether vagal afferent nerves are involved. The rats were injected intraperitoneally with capsaicin to destroy unmyelinated small vagal afferent nerve fibers. The cholecystokinin (CCK) food suppression test was performed to validate the effectiveness of the capsaicin treatment. Then, capsaicin-treated rats and vehicle-treated rats were subdivided into a control diet or a RS diet group, and fed the corresponding diet for 65 days. At the end of study, body fat, food intake, plasma peptide YY (PYY) and glucagon-like peptide 1 (GLP-1), and hypothalamic pro-opiomelanocortin (POMC), neuropeptide Y (NPY), agouti-related peptide (AgRP) gene expressions were measured. RS-fed rats had decreased body fat, increased POMC expression in the hypothalamic ARC, and elevated plasma PYY and GLP-1 in both the capsaicin and vehicle-treated rats. Hypothalamic NPY and AgRP gene expressions were not changed by RS or capsaicin. Therefore, destruction of the capsaicin-sensitive afferent nerves did not alter the response to RS in rats. These findings suggest that dietary RS might reduce body fat through increasing the hypothalamic POMC expression and vagal afferent nerves are not involved in this process. This is the first study to show that dietary RS can alter hypothalamic POMC expression.
Shen
Li
L
Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Keenan
Michael J
MJ
Martin
Roy J
RJ
Tulley
Richard T
RT
Raggio
Anne M
AM
McCutcheon
Kathleen L
KL
Zhou
Jun
J
D054369:Agouti-Related Protein / Q000187:drug effects / Q000378:metabolism; D000821:Animal Feed; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002211:Capsaicin / Q000494:pharmacology; D002766:Cholecystokinin / Q000494:pharmacology*; D004043:Dietary Fiber / Q000494:pharmacology*; D002149:Energy Intake; D005786:Gene Expression Regulation / Q000187:drug effects; D052216:Glucagon-Like Peptide 1 / Q000097:blood; D007031:Hypothalamus / Q000187:drug effects / Q000502:physiology*; D008297:Male; D019894:Peptide YY / Q000097:blood; D011333:Pro-Opiomelanocortin / Q000235:genetics*; D051381:Rats; D017207:Rats, Sprague-Dawley
D054369:Agouti-Related Protein; D004043:Dietary Fiber; D019894:Peptide YY; D011333:Pro-Opiomelanocortin; D052216:Glucagon-Like Peptide 1; D002766:Cholecystokinin; D002211:Capsaicin